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Abstract   
 
Objective: To assess whether clinical and/or laboratory-confirmed diagnosis of maternal influenza 
during pregnancy increases the risk of seizures in early childhood.  
Design: Analysis of prospectively collected registry data for children born between 2009 and 2013 in 
three high income countries. We used Cox regression to estimate country-level adjusted hazard ratios 
(aHRs); fixed effects meta-analyses were used to pool adjusted estimates. 
Setting: Population-based. 
Participants: 1 360 629 children born between 1 January 2009 to 31 December 2013 in Norway, 
Australia (New South Wales) and Canada (Ontario). 
Exposure: Clinical and/or laboratory-confirmed diagnosis of maternal influenza infection during 
pregnancy.  
Main outcome measures: We extracted data on recorded seizure diagnosis in secondary/specialist 
health care between birth and up to seven years of age; additional analyses were performed for the 
specific seizure outcomes “epilepsy” and “febrile seizures”.  
Results: Among 1 360 629 children in the study population, 14 280 (1.0%) were exposed to maternal 
influenza in utero. Exposed children were at increased risk of seizures (aHR 1.17, 95% confidence 
interval (CI) 1.07 to 1.28), and also febrile seizures (aHR 1.20, 95% CI 1.07 to 1.34). There was no 
strong evidence of an increased risk of epilepsy (aHR 1.07, 95% CI 0.81 to 1.41). Risk estimates for 
seizures were higher after influenza infection during the second and third trimester than for first 
trimester. 
Conclusions: In this large international study, prenatal exposure to influenza infection was 




What is already known on this topic 
• Maternal infections during pregnancy have been linked to childhood seizures. 
• Whether prenatal exposure to maternal influenza is linked to seizure disorders in the child is 
not known. 
What this study adds 
• We used population-based registry data from Norway, Canada and Australia to investigate 
the impact of prenatal exposure to maternal influenza on seizures in early childhood. 
• We found consistent evidence that maternal influenza in pregnancy was associated with a 
higher risk of seizures in early childhood. 
• Infections during pregnancy, including influenza, may influence susceptibility to seizures in 
childhood. Preventing influenza infection during pregnancy through vaccination may confer 





Infections during pregnancy may be associated with increased risk of adverse neurodevelopmental 
outcomes in childhood, including seizures.(1-6) Febrile seizures, the most common seizure event in 
childhood, affect 2-5% of children under five years of age.(7) Simple febrile seizures are generally 
not associated with long-term consequences, while more serious or recurrent events have been 
associated with an increased risk of epilepsy and certain psychiatric disorders.(8-10) Pregnant 
women are at higher risk of influenza-associated complications,(11) and influenza infection during 
pregnancy is associated with adverse perinatal outcomes.(12)  However, the specific role of prenatal 
exposure to maternal influenza infection in the risk of offspring seizure disorders is unclear.  
With registry data from three high-income countries (Norway, Canada, Australia) we established a 
large, population-based cohort to explore whether children with prenatal exposure to maternal 
influenza had an increased risk of seizures in early childhood.  
 
Methods 
Data sources and study population 
Birth records from 1 January, 2009 to 31 December, 2013 were obtained from the Medical Birth 
Registry of Norway,(13)  the New South Wales (NSW) Perinatal Data Collection (Australia),(14) 
and the BORN Ontario Birth Registry (Canada),(15) and linked to routine health administrative data 
from medical consultations and hospitalizations in mothers and children (supplemental methods; 
supplemental table S1).   
Maternal influenza infection  
Maternal influenza infection was defined by an influenza diagnosis during country-specific yearly 
influenza seasons (supplemental table S2). In Norway, we identified influenza diagnoses from 
primary and secondary care databases and laboratory-confirmed influenza records from the national 
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surveillance system for communicable diseases; in Ontario, we used diagnoses from primary and 
secondary care data; while in Australia, we identified influenza diagnoses from secondary care data 
and state-wide notification records for laboratory-confirmed influenza. In Norway, laboratory-
confirmed influenza records were only available for the 2009-2010 pandemic influenza season 
(defined as April 2009 to April 2010). All maternal influenza cases diagnosed in seasons subsequent 
to the 2009-2010 pandemic season were defined as seasonal influenza.  
Seizures 
We included the following diagnoses from secondary/specialist health care settings: ICD-10 codes 
R56.0 “Febrile convulsions”, R56.8 “Other and unspecified convulsions,” G40 and G41 “Epilepsy” 
(supplemental table S3). Our primary outcome was the combined group “any seizure”, defined as 
any record of these four codes. We defined the subgroup “Febrile seizures” as any record of R56.0, 
between ages three months to five years.(16) “Epilepsy” was defined by at least two recorded 
diagnoses of G40 or G41.  
Covariates 
In multivariable models we adjusted for parity, maternal age, multiple birth, season and year of 
conception, socio-economic status, maternal epilepsy, and smoking during pregnancy. Socio-
economic status was measured using country-standardized methods. Further details on covariates are 
provided in supplemental table S1.   
Statistical analyses  
Individual data sharing was not possible between countries due to privacy restrictions, therefore data 
were analysed separately within each country according to a standardized study protocol. We used 
Cox proportional hazards models, with days from birth as the underlying time metric, to estimate 
crude and adjusted hazard ratios (aHR) for any seizures in childhood after prenatal exposure to any 
maternal influenza infection (seasonal or pandemic), and further stratified by (a) seasonal influenza, 
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and (b) pandemic influenza. Any influenza infection was further categorized by trimester at time of 
diagnosis. The comparison group comprised children of mothers without influenza diagnosis while 
pregnant. Additional analyses were performed for “febrile seizures” and “epilepsy”. Children were 
followed from birth until first seizure, death, emigration, or 31 December 2016. Follow-up time 
ranged from three years to seven years, except for NSW children who were censored on their 6th 
birthday. For febrile seizures, follow up was from three months of age until the 5th birthday. We 
created unadjusted cumulative incidence curves for seizures by exposure status using pooled 
aggregate data with monthly intervals. Robust standard errors accounted for dependency between 
siblings. Up to 3.9% with missing information were excluded. The proportional hazards assumption 
was evaluated through visual inspection, and found valid. Pooled estimates were generated using a 
fixed–effects meta-analysis with inverse variance weighting of individual-country results.(17) 
Heterogeneity was assessed using the I2 statistic, calculated as 100% × (Q–df)/Q, where Q is 
Cochrane's heterogeneity statistic and df denotes degrees of freedom.(18) 
We conducted sensitivity analysis with laboratory-confirmed influenza as exposure; and with 
multivariate logistic regression, a sensitivity analysis limited to the first three years of life. To 
address whether associations were explained by inherited susceptibility to infection, we repeated the 
primary model in Norway data with exclusion of children with a recorded diagnosis of influenza 
Ethical approval 
This study was approved by the Norwegian Regional Committee for Medicine and Health Research 
Ethics (ref. 2010/2583), the Children’s Hospital of Eastern Ontario Research Ethics Board (No. 
17/04PE), the ICES Privacy Office (No. 2018-0901-137-000), the NSW Population & Health 
Services Research Ethics Committee, and the Curtin University Human Research Ethics Committee 





There were 1 360 629 eligible children born in Norway, NSW and Ontario between January 1, 2009 
and December 31, 2013 (supplemental figure S1). Of these, 14 280 (1.0%) had a mother diagnosed 
with influenza during pregnancy, of which 8762 (61.3%) had laboratory confirmed influenza. 
Characteristics of children and mothers are in table 1 (stratified by country in supplemental table S4). 
A total of 35 073 children (2.6%) had at least one record of a seizure, 22 624 children (1.7%) of a 
febrile seizure episode, 2993 children (0.2%) were defined with epilepsy, and the remainder had 
“other and unspecified convulsions”.  
The cumulative incidence of any seizures was higher in children exposed to prenatal exposure 
maternal influenza in pregnancy (3.42%; 95% confidence interval (CI) 3.13 to 3.74%) than in 
unexposed children (2.63%; 95% CI 2.60 to 2.66%) (figure 1A), with a pooled adjusted hazard ratio 
(aHR) of 1.17 (95% CI 1.07 to 1.28; figure 2; country-specific associations presented in 
supplemental table S5). Estimates were similar for seasonal influenza (aHR 1.16; 95% CI 1.03 to 
1.31) and pandemic influenza (aHR 1.17; 95% CI 1.01 to 1.35) (figure 2 and supplemental figure 
S2). For febrile seizures, the cumulative incidence was higher in exposed (2.21%; 95% CI 1.98 to 
2.47%) than in unexposed (1.69%; 95% CI 1.67 to 1.71%) (figure 1B), with adjusted HR for any 
influenza;1.20; 95% CI 1.07 to 1.34 (seasonal influenza: aHR 1.19; 95% CI 1.03 to 1.38; pandemic 
influenza: aHR 1.20; 95% CI 1.01 to 1.44; figure 3 and supplemental figure S3; country specific 
associations presented in supplemental table S6).  
Risk of seizures was elevated for influenza infection in 2nd and 3rd trimesters (2nd trimester aHR 1.24; 
95% CI 1.08 to 1.41; 3rd trimester aHR 1.20; 95% CI 1.00 to 1.44), but not with first trimester 
infection (aHR 1.03; 95% CI 0.87 to 1.22;figure 4; country-specific associations presented in 
supplemental table S7). 
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For epilepsy, the cumulative incidence of epilepsy was slightly higher in exposed children 
(supplemental figure S4). However, after adjustment the HR of epilepsy after prenatal exposure to 
maternal influenza was 1.07; 95% CI 0.81 to 1.41; supplemental figure S5; country-specific 
associations presented in supplemental table S8).  
When restricting to seizures up to age three, the pooled adjusted odds ratio was 1.20 (95% CI 1.08 to 
1.32; supplemental figure S6). Estimates for laboratory-confirmed influenza were similar to the main 
results, although the evidence for association was weaker (any seizure; aHR 1.17; 95% CI 0.80 to 
1.73; supplemental figure S7). When excluding children with an influenza diagnosis in childhood, 
the aHR was 1.17; 95% CI 1.04 to 1.33, virtually identical to the estimate for the full sample (aHR 
1.16; 95% CI 1.04 to 1.30; supplemental tables S5 and S9, Norway data only). 
 
Discussion 
With registry data from three high-income countries on more than 1.3 million children, we found that 
prenatal exposure to maternal influenza during pregnancy was associated with a 15-20% increased 
incidence of seizures in early childhood. Estimates were similar for “any seizure” and for the more 
specific “febrile seizure” outcome. There was no strong evidence of an increased risk of epilepsy.  
 
The use of large population-based registries has several strengths, including negligible bias from 
selection of participants or loss to follow-up. Also, using multiple independent registries reduces 
potential bias from possible differences in reporting. Although ascertainment of outcomes was 
similar across the three countries, the majority of influenza diagnoses in Norway and Ontario were 
clinical, while 99.9% of NSW influenza diagnoses were laboratory-confirmed. However, potential 
exposure misclassification was most likely non-differential by seizure outcomes, which may have 
attenuated associations. Women with more severe symptoms are more likely to seek health care, thus 
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our results may reflect more severe influenza illness. Still, results were consistent across countries 
and between clinical and laboratory-confirmed diagnoses, suggesting no strong bias of 
misclassification.  
It is possible that the observed associations could be influenced by inherited susceptibility to 
infection. We did not have information on all infections during childhood. However, results were 
very similar when restricting to children with no recorded influenza diagnosis during childhood. 
There could also be an inherited risk of seizure disorders, and we adjusted for maternal history of 
epilepsy, but did not have complete data on other maternal conditions.   However, genetically 
transmitted susceptibility to infection or seizures would be unlikely to differ by trimester, so our 
findings of higher estimates for exposure in second and third trimester suggests an independent effect 
of maternal infection.  
Estimates were mostly unchanged after adjustment, indicating little confounding. Still, residual 
confounding cannot be ruled out. For example, registry data on influenza vaccination was incomplete 
and was not evaluated. Pregnant women were recommended influenza vaccination in all three 
countries during the study period, though uptake is low (Canada <20% in 2014,(19) Australia 27% in 
2011(20)). Pediatric vaccination, either for influenza or other conditions, may be associated with 
transient febrile illness. However, it is unlikely to be associated with maternal influenza in 
pregnancy, and was therefore not considered a potential confounder. We did not adjust for 
gestational age, as this is a potential mediating variable, and adjustment could introduce bias.(21) 
Information on medication use was not available. Drugs commonly used to treat influenza symptoms 
not only influence severity of symptoms, but could hypothetically influence fetal 
neurodevelopment.(22)  
As this study is based on large and complete populations, we could not validate the accuracy or 
completeness of the seizure diagnoses. However, seizure episodes in young children are a dramatic 
experience, and caregivers are likely to seek medical care for first seizure episodes in children. 
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Furthermore, a diagnosis of epilepsy is likely to be established in secondary or specialist care and is 
therefore likely captured in the registries. Approximately 2.6% of children had at least one recorded 
seizure diagnosis during follow-up, and 1.7% had at least one recorded diagnosis of febrile seizure. 
Diagnostic coding practices may vary, adding to the uncertainty of outcome validity. In a study from 
Denmark, the predictive value of the ICD-10 code R56.0 for febrile seizures was high.(23) The most 
common type of seizure in the age groups in our study is febrile seizure,(24) and we assume that the 
majority of R56 records in secondary care are likely to represent febrile seizures. The broader 
outcome “any seizures” reflects a more heterogeneous mix of seizures: primarily febrile seizures, but 
also seizures due to other causes, such as acute symptomatic seizures connected to head trauma or 
infections, or the first epileptic seizure before a diagnosis of epilepsy is made, as well as epileptic 
seizures. Associations between prenatal exposure to maternal influenza and febrile seizures were of 
similar magnitude as the overall seizure outcome, indicating that influenza may have similar effects 
on several seizure subtypes, or that different seizures may overlap within the registered codes. To be 
categorised as having epilepsy, we required at least two registrations of epilepsy diagnoses during 
the study period, an approach which has been shown to have a positive predictive value of 88% when 
using Norwegian registry data.(25) At the end of our study period (children aged 3-7 years), the 
cumulative incidence of epilepsy was 0.22%. This is slightly lower than that observed in studies 
conducted in other high-income countries, in which the cumulative incidence of epilepsy by age 5 
ranged from 0.4% to 0.7%.(25-27) The lower incidence of epilepsy in our study may be due to our 
strict definition. It is also possible that children who were diagnosed with epilepsy after our follow-
up period ended were misclassified in our study as experiencing other (non-epileptic) types of 





Our findings suggest that prenatal exposure to influenza may impact susceptibility to seizures in 
childhood. It has previously been hypothesised that maternal infection in pregnancy could affect fetal 
neurodevelopment through various pathways. There could be a direct effect through infection of the 
fetal brain, or an indirect effect through maternal systemic immunological responses to infection, 
such as fever or elevated cytokine levels.(28, 29) Several studies address associations between 
infection in pregnancy and central nervous system disorders in offspring, particularly schizophrenia, 
for which some studies found an increased risk after prenatal exposure to maternal infection.(30) A 
recent study using Swedish registry data with follow-up into adulthood reported that any maternal 
infection during pregnancy requiring hospitalisation was associated with an increased risk of autism 
spectrum disorders (ASD) and depression in adulthood, but not with bipolar disease or 
psychosis.(31) Studies of prenatal exposure to influenza infection and childhood seizures have been 
lacking, and only a few studies have considered prenatal exposure to influenza and other 
neurodevelopmental outcomes in early childhood. A recent Norwegian cohort study reported modest 
associations between pandemic influenza in early pregnancy and psychomotor development at 6 
months.(32) A large US cohort study did not find evidence of an association between influenza 
infection in pregnancy and risk of ASD in childhood.(33) In several studies, associations between 
prenatal exposure to non-influenza infections (such as genitourinary infections) and childhood 
seizures (including epilepsy) have been investigated,(1-6) with results generally supporting an 
association. We found indications that childhood seizures were associated with both pandemic and 
seasonal maternal influenza, suggesting that it may be symptoms related to infection(34, 35) or 
general responses to infection, rather than a specific influenza strain, which potentially impact the 
fetal brain.  
 
Although the cumulative incidence of epilepsy was higher in children exposed to maternal influenza, 
in adjusted analysis this result had high uncertainty. It is possible that this finding indicates that any 
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potential influence of prenatal influenza exposure on the fetal brain is confined to a lower threshold 
of febrile seizures only. However, despite using three large population-based data sources, the 
number of epilepsy cases among children exposed to prenatal maternal influenza was small, and 
study follow up ended at age seven.  
Seizure episodes in childhood are common(7) and represent a substantial burden to caregivers and 
the health care system. There is strong evidence to support the safety and effectiveness of influenza 
vaccination during pregnancy,(36) and our findings suggest that preventing influenza during 
pregnancy may confer additional benefits for the child.  
 
Conclusion 
This large prospective cohort study across three high-income countries found that prenatal exposure 
to maternal influenza was associated with seizures in early childhood, although the evidence 
supporting an association with early childhood epilepsy was not strong. Associations between 
maternal influenza in pregnancy and childhood seizures were modest, and consistent across the three 
different countries. Seizures were linked to influenza infection during the second and third trimesters 
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Table 1. Maternal influenza status and characteristics of children born 2009 – 2013 in Norway, 








 Characteristic N (%)* n (%)‡ 
All children§ 1 360 629   14 280 (1.0) 
          
Maternal age at delivery         
  <20 39 388 (2.9) 443 (1.1) 
  20-24 175 085 (12.9) 2033 (1.2) 
  25-29 384 788 (28.3) 4384 (1.1) 
  30-34 458 829 (33.7) 4707 (1.0) 
  35-39 247 825 (18.2) 2254 (0.9) 
  ≥40 54 714 (4.0) 459 (0.8) 
Maternal smoking in pregnancy         
  No 1 174 081 (86.3) 11 565 (1.0) 
  Yes 145 023 (10.7) 1558 (1.1) 
  Information declined¶ 41 525 (3.1) 1157 (2.8) 
Maternal history of epilepsy         
  Yes 5296 (0.4) 101 (1.9) 
  No 1 355 333 (99.6) 14 179 (1.0) 
Parity         
0 586 634 (43.1) 5169 (0.9) 
1 477 322 (35.1) 5760 (1.2) 
  ≥2 296 673 (21.8) 3351 (1.1) 
Gestational age at birth         
  Preterm (<37 weeks) 95 994 (7.1) 961 (1.0) 
  Term (≥37 weeks) 1 264 635 (92.9) 13 319 (1.1) 
Multiple birth         
  Yes 43 765 (3.2) 429 (1.0) 
  No 1 316 864 (96.8) 13 851 (1.1) 
Season of conceptionǁ         
  Winter  339 763 (25.0) 2589 (0.8) 
  Spring  324 349 (23.8) 2785 (0.9) 
  Summer  340 333 (25.0) 4433 (1.3) 
  Autumn  356 184 (26.2) 4473 (1.3) 
*Column percentages 
†Maternal  influenza diagnosis during pregnancy. Norway: any diagnosis in primary care using International Classification of Primary 
Care code R80, or in secondary or specialist health care using International Statistical Classification of Diseases revision 10 codes J09, 
J10 or J11, or laboratory-confirmed pandemic influenza. NSW: any laboratory-confirmed or hospital diagnosed influenza infection 
during pregnancy. Ontario: any diagnosis in primary care using modified ICD-9 code 487, or in urgent or in-patient health care using 
19 
 
International Statistical Classification of Diseases revision 10 codes J09, J10 or J11. N.b. Influenza diagnoses only valid during 
country-specific yearly influenza seasons   
‡Row percentages  
§Children born between January 1, 2009 and December 31, 2013        
¶Category  in use for Norway data only     
ǁNorthern Hemisphere : Winter (Dec-Feb), Spring (Mar-May), Summer (Jun-Aug), Autumn (Sep-Nov); Southern Hemisphere: Winter 





Figure 1. Cumulative incidence of (a) any seizures and (b) febrile seizures, according to 
exposure to maternal influenza during pregnancy: Pooled data for Norway, New South Wales 



















Figure 4: Meta analyses of the associations between prenatal influenza and all seizures in early 
childhood, by trimester of infection  
 
